Celldex (NASDAQ: CLDX) reported Q3 EPS of ($0.64), $0.03 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $3.19 million versus the consensus estimate of $835.56 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.